- Lucy Douglas, clinical assistant in rheumatology (lucydouglas{at}doctors.org.uk),
- Mohammed Akil
- Correspondence to: L Douglas
- Accepted 10 January 2006
A 58 year old woman was diagnosed as having polymyalgia rheumatica in 2000. Her blood pressure was slightly raised (140/74 mm Hg). Her past medical history was otherwise unremarkable and her condition stable.
She takes 5 mg prednisolone a day, up to six over the counter Panadol tablets (GlaxoSmithKline, Brentwood; 500 mg paracetamol) a day, and Calcichew D3 Forte (Shire, Basingstoke; 1.25 g calcium carbonate and 10 μg colecalciferol) twice a day.
She complained of headaches, dizziness, and lethargy at a follow-up appointment in March 2004. She was hypertensive, with readings averaging 210/110 mm Hg. We advised her to see her general practitioner to recheck this.
Her blood pressure varied between 158/79 and 210/110 mm Hg over the next few days. Then she mentioned that eight weeks previously she had switched from Panadol tablets to soluble Panadol. Her lifestyle had apparently remained otherwise unchanged.
Each soluble Panadol contains 427 mg sodium. Her daily intake of sodium from six soluble tablets was 2.562 g, not including dietary sodium. The UK government recommends a daily intake of 2 g sodium (5 g salt) for women,1 and the World Health Organization recommends limiting sodium intake.2 Salt intake is linked to blood pressure.3 After returning to insoluble Panadol, her blood pressure was 145/85 mm Hg, confirmed by her general practitioner.
The increase in blood pressure seems temporally related to the switch in drug, which substantially increased in her sodium intake. This case shows the hypertensive effect that the high sodium content in a soluble paracetamol preparation may cause, particularly in susceptible patients. It also emphasises the importance of inquiring about over the counter drugs.
GlaxoSmithKline has no record of similar reports and felt it “unlikely that the sodium caused such a large increase in blood pressure,” given that restricting dietary sodium in normotensive and hypertensive populations produces modest reductions in blood pressure.4 The UK Committee on Safety of Medicines knows of no similar cases, but its database relates primarily to paracetamol's adverse effects and not non-drug ingredients.
Footnotes
-
Funding None.
-
Competing interests None declared.







CiteULike
Connotea
Del.icio.us
Digg
Facebook
Mendeley
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Re: Ventilator associated pneumonia
Published 30 May 2012
Re: Restless legs syndrome
Published 30 May 2012
Author's reply
Published 30 May 2012
Re: Full access to trial data holds many benefits and a few pitfalls, conference hears
Published 30 May 2012
Restless Legs Syndrome: Fact or Fiction
Published 30 May 2012
Most responses
Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10 (12 responses)
Published 10 May 2012 - 23:32
The psychiatric oligarchs who medicalise normality (9 responses)
Published 2 May 2012 - 15:42
Are doctors justified in taking industrial action in defence of their pensions? No (8 responses)
Published 8 May 2012 - 12:21
Are doctors justified in taking industrial action in defence of their pensions? Yes (8 responses)
Published 8 May 2012 - 12:21
The hardest thing: admitting error (7 responses)
Published 2 May 2012 - 12:27